iSpecimen Inc (ISPC)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.66M
Last updated: Nov 17, 2026 at 4:26 PM ET
iSpecimen Inc (ISPC) Statistics
iSpecimen (ISPC) has a market cap of $1.66M. It kept -1797.33% of revenue as net income over the last 12 months. It holds $5.56M more cash than debt, 334.96% of its market cap.
Total Valuation
| Market Cap | $1.66M |
|---|---|
| Latest price (Nov 17, 2026) | $0.60 |
Key Dates
| Last Earnings Date | Aug 14, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.1x and 0.3x. Its year-end P/S ranged from 0.2x to 1.2x from 2022 to 2024.
| P/S Ratio | 2.1x |
|---|---|
| P/B Ratio | 0.3x |
| P/TBV Ratio | 1.3x |
Price Statistics
The stock is down 97.63% over 52 weeks and trades 41.75% below its 50-day average.
| Beta (1Y) | 1.53 |
|---|---|
| 52-Week Change | -97.63% |
| 1-Month Change | -34.50% |
| 3-Month Change | -74.95% |
| 6-Month Change | -83.76% |
| 5-Year Change | -99.99% |
| Total Return (1Y) | -97.63% |
| Total Return (3Y CAGR) | -89.03% |
| Total Return (5Y CAGR) | -82.73% |
| Max Drawdown (1Y) | -97.43% |
| Max Drawdown (3Y) | -99.88% |
| Sharpe Ratio (1Y) | -3.19 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $1.03 |
| 200-Day Average | $4.04 |
| 52-Week Range | $0.57 to $27.44 |
| RSI (14 Days) | 22.0 |
| Average Volume (20 Days) | 261.45K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.16x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.16x |
|---|---|
| Quick Ratio | 1.16x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -266.72% and return on assets is -111.86% over the last 12 months.
| Return on Equity (ROE) | -266.72% |
|---|---|
| Return on Assets (ROA) | -111.86% |
| Return on Capital Employed (ROCE) | -255.75% |
| ROA (5Y Average) | -76.11% |
| ROIC (5Y Average) | -99.89% |
| Asset Turnover | 0.06x |
| Receivables Turnover | 16.84x |
Scores
ISPC has an Altman Z-Score of -16.10, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -16.10 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $603.74K over the last 12 months is down 81.99% from the 12 months before.
| Revenue | $603.74K |
|---|---|
| Revenue Growth (YoY) | -81.99% |
| Gross Profit | -$253.95K |
| Operating Income | -$8.79M |
| Pretax Income | -$10.85M |
| Net Income | -$10.85M |
| EBIT | -$10.82M |
| Reported EPS (TTM) | -$31.72 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 41.96% of the $9.70M in total assets.
| Cash and Equivalents | $5.56M |
|---|---|
| Total Debt | $0 |
| Net Cash | $5.56M |
| Net Cash Per Share | $2.58 |
| Working Capital | $870.94K |
| Shareholder Equity | $4.07M |
| Book Value Per Share | $1.89 |
| Tangible Book Value | $962.26K |
| Tangible Book Per Share | $0.45 |
| Total Assets | $9.70M |
| Total Liabilities | $5.63M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$7.67M |
|---|---|
| FCF Per Share | -$3.60 |
| Depreciation and Amortization | $978.25K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -1455.33%.
| Gross Margin | -42.06% |
|---|---|
| Operating Margin | -1455.33% |
| Pretax Margin | -1797.33% |
| Net Margin | -1797.33% |
| EBIT Margin | -1792.57% |
| Gross Margin (5Y Average) | 40.55% |
Growth
Revenue fell 42.97% a year over 3 years.
| Revenue Growth (3Y CAGR) | -42.97% |
|---|---|
| Revenue Growth (5Y CAGR) | -25.10% |
Dividends and Yields
ISPC does not pay a dividend.
| Buyback Yield | -367.98% |
|---|---|
| Shareholder Yield | -367.98% |
Stock Splits
The last split was a 1-for-40 reverse split on Apr 28, 2026.
| Last Split Date | Apr 28, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:40 |
Peer Position
Against 8 similar companies, ISPC has the 5th highest P/S.
P/S RatioPeer median 3.4x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +3.05%
| P/S Ratio | 2.1x vs 3.4x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -81.99% vs +3.05% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ISPC
What is ISPC's market cap?
iSpecimen has a market cap of $1.66M.
How many shares of ISPC are outstanding?
iSpecimen has 2.16M shares outstanding.
Does ISPC pay a dividend?
No. iSpecimen does not pay a dividend.
How much debt does ISPC have?
iSpecimen has $0 of total debt and $5.56M of cash and equivalents, a net cash position of $5.56M.
ISPC pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors